#complement-inhibition — Friday, October 23, 2026 (1 items)
| 35 | ℹ |
Ravulizumab in IgA Nephropathy - Interim Analysis of a Phase 3 Trial.
(nejm.org)
|
New England Journal of Medicine 2026-10-23 | #iga-nephropathy #complement-inhibition #clinical trial #glomerulonephritis #proteinuria |